Mirati Ther Insiders
MRTXDelisted Stock | USD 31.32 0.15 0.48% |
Mirati Ther employs about 587 people. The company is managed by 9 executives with a total tenure of roughly 7 years, averaging almost 0.0 years of service per executive, having 65.22 employees per reported executive. Break down of Mirati Ther's management performance can provide insight into the company performance.
James Christensen SVP Chief Scientific Officer and Sr. VP |
Mirati |
Mirati Ther Management Team Effectiveness
The company has return on total asset (ROA) of (0.393) % which means that it has lost $0.393 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6995) %, meaning that it created substantial loss on money invested by shareholders. Mirati Ther's management efficiency ratios could be used to measure how well Mirati Ther manages its routine affairs as well as how well it operates its assets and liabilities.Mirati Ther Workforce Comparison
Mirati Ther is regarded fourth in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 5,594. Mirati Ther retains roughly 587 in number of employees claiming about 10% of equities under Health Care industry.
Mirati Ther Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Mirati Ther insiders, such as employees or executives, is commonly permitted as long as it does not rely on Mirati Ther's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Mirati Ther insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Ondrey Aaron over a year ago Acquisition by Ondrey Aaron of 17021 shares of Mirati Ther subject to Rule 16b-3 | ||
Ondrey Aaron over a year ago Mirati Ther exotic insider transaction detected | ||
Moriarty John B over a year ago Mirati Ther exotic insider transaction detected | ||
Laurie Stelzer over a year ago Sale by Laurie Stelzer of 4647 shares of Mirati Ther | ||
David Meek over a year ago Sale by David Meek of 3179 shares of Mirati Ther |
Mirati Ther Notable Stakeholders
A Mirati Ther stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Mirati Ther often face trade-offs trying to please all of them. Mirati Ther's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Mirati Ther's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
James Christensen | Chief Scientific Officer and Sr. VP | Profile | |
Benjamin MBA | Chief Officer | Profile | |
Michael Paolucci | Chief Officer | Profile | |
Alan MD | Ex Officer | Profile | |
Kelly Covello | VP Affairs | Profile | |
Ryan Asay | VP Affairs | Profile | |
Laurie Stelzer | Chief Officer | Profile | |
Reena Desai | Chief Sec | Profile | |
David Meek | CEO Director | Profile |
About Mirati Ther Management Performance
The success or failure of an entity such as Mirati Ther often depends on how effective the management is. Mirati Ther management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Mirati management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Mirati management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. Mirati Therapeutics, Inc. was founded in 1995 and is headquartered in San Diego, California. Mirati Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 413 people.
Please note, the imprecision that can be found in Mirati Ther's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Mirati Ther. Check Mirati Ther's Beneish M Score to see the likelihood of Mirati Ther's management manipulating its earnings.
Mirati Ther Workforce Analysis
Traditionally, organizations such as Mirati Ther use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Mirati Ther within its industry.Mirati Ther Manpower Efficiency
Return on Mirati Ther Manpower
Revenue Per Employee | 21.2K | |
Revenue Per Executive | 1.4M | |
Net Loss Per Employee | 1.3M | |
Net Loss Per Executive | 82.3M | |
Working Capital Per Employee | 1.6M | |
Working Capital Per Executive | 105.5M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in Mirati Stock
If you are still planning to invest in Mirati Ther check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Mirati Ther's history and understand the potential risks before investing.
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
CEOs Directory Screen CEOs from public companies around the world | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |